Distro — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
Sosei Heptares
sosei group corporation discovers, develops, and commercializes biopharmaceutical products worldwide. its marketed products include ultibro/breezhaler and seebri/breezhaler for the treatment of chronic obstructive pulmonary disease; and oravi, an oropharyngeal candidiasis. the company's product pipeline consists of azd4635, an adenosine a2a antagonist, which is in phase ii clinical trial for the treatment of solid tumors and metastatic castration resistant prostate cancer; htl0016878, a muscarinic m4 agonist, which is in phase i clinical trial for the treatment of alzheimer's disease; and dual muscarinic m1/m4 agonist, which is in pre-clinical stage for the treatment of alzheimer's disease. it also develops htl0014242, a mglu5 small molecule negative-allosteric modulator, which is in phase i clinical trial for the treatment of certain neurological order; sstr agonist, a novel somatostatin peptide agonist, which is in phase i clinical trial for the treatment of endocrine disorders; htl0
Frequently asked questions about Sosei Heptares
Let us help answer the most common questions you might have.
Where is Sosei Heptares located?
Sosei Heptares' headquarters is located at Tokyo, Tokyo, Japan
What is Sosei Heptares' official website?
Sosei Heptares' official website is soseiheptares.com
How many employees does Sosei Heptares have?
Sosei Heptares has 151 employees
What industry does Sosei Heptares belong to?
Sosei Heptares is in the industry of: Biotechnology
Distro — Free Sales Engagement Platform
Sequences, cloud call center, shared inbox, form tracking and more — on a single platform. Double your sales team's output with fewer tools.
Create a sequence — it's free
